Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00557960 · ClinicalTrials.gov registry record · Phase 3
ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD
A Phase 3 study, sponsored by Shire.
- Completed
- Registry status
- Phase 3
- Development phase
- 36
- Enrollment target
NCT00557960 is a Phase 3 study that has completed, run by Shire. The registered enrollment target is 36 participants.
The verdict
NCT00557960, a Phase 3 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 36 participants
- Enrollment target
Study Summary
Evaluate the efficacy of treatment with ADDERALL XR and STRATTERA compared to placebo on simulated driving safety and performance of young adults with ADHD as measured by Driving Safety Scores derived by the Driving Simulator.
Interventions
- DRUG Atomoxetine hydrochloride
- DRUG Mixed salts of a single-entity amphetamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2004-02-25 |
| Est. Completion | 2004-10-25 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00557960
The ClinicalTrials.gov registry entry for NCT00557960 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Atomoxetine hydrochloride is the first listed.
NCT00557960 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00557960 about?
NCT00557960 is a clinical study titled "ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD". Evaluate the efficacy of treatment with ADDERALL XR and STRATTERA compared to placebo on simulated driving safety and performance of young adults with ADHD as measured by Driving Safety Scores derived by the Driving Simulator.
What is the current status of trial NCT00557960?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 36 participants. The study started on 2004-02-25. Estimated completion is 2004-10-25.
What interventions are being tested in trial NCT00557960?
The interventions under investigation include: Atomoxetine hydrochloride (DRUG), Mixed salts of a single-entity amphetamine (DRUG).
Who is sponsoring clinical trial NCT00557960?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.